|
|
|
Insider
Information: |
Przybyl Arthur |
Relationship: |
President and CEO, Dir... |
City: |
Buffalo Grove |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
430,125 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,804,713 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
430,125 |
|
|
Total
Value |
$12,804,713 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Akorn Inc |
AKRX |
President, CEO, Director |
2008-12-31 |
239,816 |
2003-10-03 |
0 |
Premium* |
|
ANI Pharmaceuticals Inc |
ANIP |
President and CEO, Dir... |
2020-04-07 |
190,309 |
2013-06-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2020-04-07 |
4 |
D |
$43.93 |
$92,912 |
D/D |
(2,115) |
190,309 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2020-04-06 |
4 |
D |
$43.22 |
$141,848 |
D/D |
(3,282) |
192,424 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2020-03-31 |
4 |
D |
$40.74 |
$109,142 |
D/D |
(2,679) |
195,706 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2020-03-28 |
4 |
D |
$37.76 |
$158,743 |
D/D |
(4,204) |
198,385 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-04-16 |
4 |
D |
$68.60 |
$116,071 |
D/D |
(1,692) |
232,589 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-04-07 |
4 |
D |
$70.50 |
$149,108 |
D/D |
(2,115) |
234,281 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-04-06 |
4 |
D |
$70.50 |
$231,381 |
D/D |
(3,282) |
236,396 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-03-31 |
4 |
D |
$70.54 |
$188,906 |
D/D |
(2,678) |
239,678 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,280 |
242,356 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-03-19 |
4 |
S |
$63.51 |
$179,289 |
D/D |
(2,823) |
205,076 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2019-03-18 |
4 |
S |
$63.53 |
$1,575,671 |
D/D |
(24,802) |
205,076 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-05-22 |
4 |
D |
$61.88 |
$85,085 |
D/D |
(1,375) |
207,256 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-04-16 |
4 |
D |
$60.21 |
$96,998 |
D/D |
(1,611) |
208,631 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-04-07 |
4 |
D |
$57.06 |
$114,919 |
D/D |
(2,014) |
210,242 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
29,100 |
212,256 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-31 |
4 |
D |
$58.22 |
$148,461 |
D/D |
(2,550) |
183,156 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-14 |
4 |
S |
$62.03 |
$620,300 |
D/D |
(10,000) |
185,706 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-13 |
4 |
S |
$61.52 |
$1,852,843 |
D/D |
(30,000) |
195,706 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-12 |
4 |
OE |
$6.36 |
$99,998 |
D/D |
15,723 |
225,706 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-01 |
4 |
S |
$60.59 |
$1,468,695 |
D/D |
(23,986) |
209,983 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2018-03-01 |
4 |
OE |
$6.36 |
$643,287 |
D/D |
23,986 |
233,969 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2017-05-22 |
4 |
D |
$47.01 |
$46,587 |
D/D |
(991) |
210,833 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2017-04-17 |
4 |
D |
$51.22 |
$59,466 |
D/D |
(1,161) |
211,824 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2017-04-07 |
4 |
D |
$51.24 |
$74,349 |
D/D |
(1,451) |
212,985 |
0 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
President and CEO |
|
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
23,750 |
214,436 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|